Intracranial hemangiopericytoma: study of 12 cases.

摘要: Most hemangiopericytomas (HPCs) are located in the musculoskeletal system and skin, while intracranial location is rare. They represent 2 to 4% large series of meningeal tumours, thus accounting for less than 1% all tumours. Many authors have argued about true origin this tumour. The current World Health Organization classification Central Nervous System tumours distinguishes HPC as an entity its own, classified it into group “mesenchymal, non-meningothelial tumours”. Radical surgery treatment choice, but must be completed with postoperative radiotherapy, which has proved therapy most strongly related final prognosis. HPCs a relentless tendency local recurrence metastases outside central nervous can appear even many years after diagnosis adequate primary